Peptides For Health And Longevity: Promising, Dubious or Dangerous?

Getting your Trinity Audio player ready...

There has been mounting hype surrounding peptides – small chains of amino acids (protein building blocks) that can act as signalling molecules. Numerous online influencers and celebrities have been promoting the idea that certain peptides (often delivered via injection) can promote general health and wellbeing, treat specific diseases and even slow ageing. Regrettably, the vast majority of these claims have very little scientific backing. In this article, we’re going to break down how peptide treatments might improve human health, the true extent of the supporting scientific evidence, and why taking peptides might be a riskier proposal than it first appears.

Promising

To understand why some people think peptides could hold promise for improving human health, we first have to understand what they are. Peptides are short chains of amino acids – the building blocks of proteins. Longer chains (around 50 peptides long) are known as polypeptides, which fold in on themselves and may combine with other polypeptides to form a protein with a specific shape and function. Most individual peptides are too small to form more complicated structures like enzymes, receptors and the channels and pumps that move molecules in and out of our cells. Yet peptides still fulfil very important functions as hormones and other signalling molecules. The most well known peptide is probably insulin, the blood sugar-lowering hormone. Other peptides you may have heard of include glucagon (insulin’s ‘opposite’), the hunger and satiety hormones ghrelin and leptin, endorphins, various growth factors and amyloid beta.

So, peptides have important functions within the body, but so do a lot of molecules. Where does the idea that giving people additional peptides can improve general health and slow ageing come from? Well, many of the important molecular pathways that appear to regulate the ageing process are affected by peptides. Some peptides like BPC-157 (body protection compound), one of the better known and widely promoted peptides, appear to suppress inflammation, which is thought to drive many age-related diseases. Others like SS-31 have been reported to improve the health and function of mitochondria (the cellular power plants whose functional decline is considered to be a hallmark of ageing). Yet more peptides may help to clear senescent cells (dysfunctional cells that have stopped dividing and promote cancer and other disease in surrounding tissue).

There are also some intriguing findings from animal models concerning peptides. BPC-157, for example, was in one study found to be associated with reduced damage following traumatic brain injury in mice, and more rapid wound healing in another study in rats.

So, there’s some reason to believe that peptides could modulate the ageing process and might be worthy of further investigation in humans, based on their molecular functions and animal evidence. Some peptides also appear to be performance-enhancing due to their ability to stimulate the release of growth hormone and thereby increase muscle mass. It’s easy to see the appeal of taking peptides in the hope of taking advantage of one or more of these effects. However, as you probably know, the effects of drugs in cells and animals often don’t translate well to humans. So what does the human evidence look like?

Dubious

Before we talk about the scientific evidence for peptides that are promoted for general health, it’s important to be clear that some peptides are well established as effective and safe treatments for specific conditions. The most obvious example is insulin, which is of course given to diabetics with severe insulin resistance or who do not produce sufficient insulin themselves. More recent examples of peptides being clinically approved for the treatment of a condition are weight loss drugs like ozempic (semaglutide) and mounjaro (tirzepatide). These drugs are synthetic or modified versions of a natural peptide, glucagon-like-peptide-1 (GLP-1).

There are also some early clinical success stories when it comes to treating certain diseases with other peptides. For example, patients with sarcopenia (muscle wasting) might receive some benefit from growth hormone-releasing peptides. As an anti-ulcerative peptide with anti-inflammatory properties, BPC -157 is in the very early phases of clinical trials for the treatment of inflammatory bowel disease.

However, there is a very big difference between experimental peptides, primarily being taken for performance, general health and ageing or for self-medication of a specific medical condition, and the clinically approved peptides like ozempic. Almost all claims concerning the general health benefits of peptides are massively exaggerated or misleading versions of what has actually been scientifically proven.

Take the example of MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c), a peptide that has been promoted for muscle building, weight loss without muscle loss and anti-ageing effects. Proponents of this peptide will explain how it targets AMP-activated protein kinase (AMPK), a master regulator of energy metabolism that is thought to play an important role in ageing, and that MOTS-c can improve mitochondrial health and exercise performance. These claims do appear to be correct according to cellular and animal evidence. However, numerous websites and influencers will then go on to discuss these benefits as thought they are proven in humans, while citing studies conducted on human cells. They will even going so far as to discuss specific dosing strategies. But what is the actual evidence for any of this in human clinical trials? As far as we can tell, at the time of writing (Dec 2025) there has been one human trial of a MOTS-c analogue. This trial included 88 people with non-alcoholic fatty liver disease and found a trend towards weight loss.

A similar picture emerges for another popular peptide, SS-31 (aka elamipritide), which also targets mitochondria. One source claims that the ‘overwhelming’ number of health benefits of SS-31 are evident from the fact that over 130 papers concerning SS-31 have been published on it since 2005. Putting aside the fact that 130 papers is actually a rather underwhelming number of publications for a 20 year time span, almost none of those papers are investigating the effects of administering SS-31 to humans. Those that are doing so focused on specific diseases like Barth syndrome, an ultra-rare genetic condition involving abnormal mitochondria.

As we have already mentioned, BPC-157 has been shown to enhance tissue repair, suppress inflammation and potentially protect the brain in animal studies. Numerous influencers extol the virtues of this peptide and its many health benefits, citing how it helped them to recover from muscle injury or helped ameliorate their medical condition. However, once again, the human evidence for any benefits for this peptide is extremely scarce – a handful of small pilot studies primarily designed to identify serious adverse reactions, not whether the peptide is effective in achieving any of its claimed health benefits. Among the only reported benefits of BPC-571 in humans include a reduction in knee pain in 11/12 patients receiving knee injections of the peptide, but this was a retrospective study with no control group, so not exactly the highest quality of evidence.

All this is not to say that some or all of these peptides won’t turn out to be beneficial, at least in specific circumstances. After all, all drugs currently approved for use today were once experimental drugs. Some peptides are in the early phases of investigation for the treatment of certain chronic diseases, and some people claim that peptides have ameliorated their specific condition. However, without good quality scientific data to support these anecdotal claims, there is no way to know if the potential benefits of peptides would outweigh the risks, which will be the next and final topic of discussion.

Dangerous?

Peptides may be ‘natural’ (or at least synthetic forms of natural peptides), but this doesn’t necessarily mean they are safer to inject than any other drug. The kinds of peptides being provided outside of medical supervision are essentially experimental drugs in the very earliest phases of human testing. They carry the risk of severe and life-threatening allergic reactions. Aside from this short term risk, we have essentially no scientific data concerning what happens when people take peptides for an extended period of time. There have been some case reports of people in their 20s developing heart failure while taking peptides, but because these people are often taking a cocktail of other performance-enhancing drugs as well, it’s impossible to say whether the peptides contributed to the heart failure. There are also mechanistic reasons to believe that some peptides might promote cancer.

The potential dangers of peptides are exacerbated by the fact that people are often encouraged to take a ‘stack’ of different peptides for a specific purpose, such as the so-called ‘wolverine stack’ (a combination of BPC-157 and TB500, another peptide that appears to promote tissue repair) for its supposed ability to accelerate wound healing. And without the controlled environment of a clinical trial, it is impossible to know whether the peptides were responsible (and so, which one it was) in those cases where someone does develop a severe condition after taking them for a while. You are also much less likely to hear about these stories than you are to hear anecdotal accounts of how peptides improved someone’s health – the latter fare much better with internet algorithms.

Last but not least, most peptides exist in a medical grey zone, lacking approval from any regulatory authority, and are not allowed to be sold for human consumption in most countries. Sellers do however frequently sell peptides for ‘research purposes’, labelling them as not for human consumption. There is no guarantee that these peptides have been produced to appropriate manufacturing standards, adding yet another layer of risk.

The Take-Home Message

There’s some interesting preclinical data concerning many peptides, and it’s easy to see their appeal. The animal benefits, if they turn out to apply to humans as well, could be very impactful. The fact that peptides are in most cases similar or identical to those produced naturally in the body may lull people into a false sense of security about the potential risks. The unfortunate reality is that peptides are research chemicals with little to no human evidence for their long-term safety or health benefits. It usually takes years if not decades of research to properly establish whether such a compound is safe and effective, and unfortunately there’s not that much research being conducted on these peptides, at least for the moment.

As the famous saying goes: ‘The larger the island of knowledge, the longer the shoreline of the unknown’. As legitimate science slowly grows that island, some people prefer to sail the high seas. It’s usually better not to venture too far from the shore…